Over the past several days there have been multiple articles in which the ACES agency, run by the Levinson Brothers, has been scrutinized due to the fact that the vast majority of players suspended in the Biogenesis scandal are or were represented by the agency. ACES was censured by the MLBPA last year in the wake of Melky Cabrera’s suspension for its failure to properly supervise its former consultant, Juan Carlos Nunez, who is alleged to have steered players to Biogenesis and who was behind the efforts of Cabrera to deflect blame for his positive test via the formation of a phony website.
On Monday we reported that no additional adverse action would be taken against ACES. Yesterday we noted how multiple agents are dissatisfied with this and have spoken out against the agency. Today Bob Nightengale reports that Major League Baseball remains interested in the matter:
Major League Baseball, armed with evidence that every player suspended 50 games Monday in its intensive drug probe were linked by the same agency, plans to turn its attention to baseball agents, particularly Juan Carlos Nunez and the ACES agency.
It may be “turning its attention” to ACES, but there is nothing MLB can do about it. Agents are sanctioned by the MLBPA, not Major League Baseball. The MLBPA has sole jurisdiction over agents and it has already said that there is no evidence that ACES was aware of or condoned Nunez’s behavior. There is no basis for discipline there and MLBPA will not be taking any. To say MLB is concerned about it is akin to saying MLB is concerned about the weather. It can talk about it all it wants, but it can’t do a thing about it.
Going forward, this story should be seen for what it is: agents trying to gain an advantage over ACES via attempts to leverage bad press. Which, as we noted yesterday, is par for the course for agents. All agents, always. It’s like a sewing circle.
Update (8:51 PM EST): The deal is in place, according to Heyman.
Update (8:27 PM EST): Derrick Goold of the St. Louis Post-Dispatch reports that the Cardinals made an “over-the-top offer” to Fowler to ensure he’d sign.
Frank Cusumano of KSDK Sports reports that free agent outfielder will take a physical in St. Louis on Friday. Presumably, that means that Fowler and the Cardinals have gotten pretty far along in negotiations.
Jon Heyman of FanRag Sports recently reported that Fowler was looking for $18 million per year. The Blue Jays reportedly made an offer to Fowler in the four-year, $16 million range several days ago. The Cardinals’ offer to Fowler, if there is indeed one, is likely somewhere between the two figures.
Fowler, 30, is coming off of a fantastic year in which he helped the Cubs win their first World Series since 1908. During the regular season, he hit .276/.393/.447 with 13 home runs, 48 RBI, 84 runs scored, and 13 stolen bases in 551 plate appearances.
Fowler rejected the Cubs’ $17.2 million qualifying offer last month. While the QO compensation negatively affected Fowler’s experience in free agency last offseason — he didn’t sign until late February with the Cubs — his strong season is expected to make QO compensation much less of an issue.
Tommy Stokke of RanRag Sports reports that the Braves and Rangers agreed to a trade. According to ESPN’s Keith Law, the Braves will receive pitcher Luke Jackson from the Rangers in exchange for pitchers Tyrell Jenkins and Brady Feigl.
Jackson, 25, is under team control through 2022. He has logged only 18 innings in the majors, yielding 14 runs on 22 hits and eight walks with three strikeouts. While Jackson has struggled with control, the Braves likely see upside because his fastball sits in the mid- to high-90’s.
Jenkins, 24, is also under team control through 2022. The right-hander made eight starts and six relief appearances in his first major league season in 2016, putting up a 5.88 ERA with a 26/33 K/BB ratio over 52 innings.
Feigl, 25, was an undrafted free agent and was signed by the Braves in 2013. The lefty underwent Tommy John surgery in 2015 and briefly rehabbed in rookie ball this past season.